会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • SECRETED AND CELL SURFACE GENES EXPRESSED IN BENIGN AND MALIGNANT COLORECTAL TUMORS
    • 分泌和细胞表面基因表达于胆管和恶性色素性肿瘤
    • WO2003022863A1
    • 2003-03-20
    • PCT/US2002/028518
    • 2002-09-09
    • THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINEBUCKHAULTS, PhillipKINZLER, Kenneth, W.VOGELSTEIN, Bert
    • BUCKHAULTS, PhillipKINZLER, Kenneth, W.VOGELSTEIN, Bert
    • C07H21/04
    • C07K14/495C07K14/47C07K14/705
    • Serial analysis of gene expression (SAGE) was used to identify transcripts encoding secreted or cell-surface proteins that were expressed in benign and malignant tumors of the colorectum. A total of 290,394 tags were analyzed from normal, adenomatous and cancerous colonic epithelium. Of the 21,343 different transcripts observed, 957 were found to be differentially expressed between normal and adenoma or between normal and cancer. Forty-nine transcripts were elevated ≥ 20-fold in adenomas, 40 transcripts were elevated ≥ 20-fold in cancers, and nine transcripts were elevated ≥ 20-fold in both. Product of six these nine transcripts (TGFBI, LYS, RDP, MIC-1, REGA, and DEHL) were predicted to be secreted or to reside on the cell surface and these were analyzed in more detail. The abnormal expression levels predicted by SAGE were confirmed by quantitative PCR analyses of each of these six genes. Moreover, the cell types responsible for the elevated expression were identified by in situ hybridization and by PCR analyses of epithelial cells immunoaffinity purified from primary tumors.
    • 基因表达(SAGE)的序列分析用于鉴定在结肠直肠癌和恶性肿瘤中表达的编码分泌的或细胞表面蛋白的转录物。 从正常,腺瘤和癌性结肠上皮分析总共290,394个标签。 在观察到的21,343种不同的转录物中,957被发现在正常和腺瘤之间或在正常和癌症之间差异表达。 在腺瘤中,49个转录本升高了20倍,40个转录物在癌症中升高了20倍,而9个转录物在两者中升高了20倍。 预计这六种转录本(TGFBI,LYS,RDP,MIC-1,REGA和DEHL)的六种产物被分泌或驻留在细胞表面上,并且更详细地分析这些转录物的产物。 通过对这6种基因中的每一种进行定量PCR分析证实SAGE预测的异常表达水平。 此外,通过原位杂交和通过从原发性肿瘤纯化的上皮细胞免疫亲和素的PCR分析来鉴定负责升高的表达的细胞类型。
    • 4. 发明申请
    • C-MYC IS ACTIVATED BY BETA-CATENIN AND TCF-4
    • C-MYC是由卡培他滨和TCF-4激活的
    • WO2000011195A1
    • 2000-03-02
    • PCT/US1999/018774
    • 1999-08-20
    • THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINEHE, Tong-ChuanVOGELSTEIN, BertKINZLER, Kenneth, W.
    • HE, Tong-ChuanVOGELSTEIN, BertKINZLER, Kenneth, W.
    • C12N15/63
    • C07K14/47A61K38/00A61K48/00C07K14/4705C12Q1/6897
    • The APC tumor suppressor protein binds to β-catenin, a protein recently shown to interact with Tcf/Lef transcription factors. Here, the gene encoding a Tcf family member that is expressed in colonic epithelium ( hTcf-4 ) was cloned and characterized. hTcf-4 transactivates transcription only when associated with β-catenin. Nuclei of APC -/- colon carcinoma cells were found to contain a stable β-catenin-hTCF-4 complex that was constitutively active, as measured by transcription of a Tcf reporter gene. Reintroduction of APC removed β-catenin from hTcf4 and abrogated the transcriptional transactivation. Constitutive transcription of TCF target genes, caused by loss of APC function, may be a crucial event in the early transformation of colonic epithelium. It is also shown here that the products of mutant APC genes found in colorectal tumors are defective in regulating β-catenin/Tcf-4 transcriptional activation. Furthermore, colorectal tumors with intact APC genes were shown to contain subtle activating mutations of β-catenin that altered functionally significant phosphorylation sites. These results indicate that regulation of β-catenin is critical to APC's tumor suppressive effect and that this regulation can be circumvented by mutations in either APC or β-catenin.
    • APC肿瘤抑制蛋白结合β-连环蛋白,最近显示出与Tcf / Lef转录因子相互作用的蛋白质。 这里,克隆并表征编码在结肠上皮(hTcf-4)中表达的Tcf家族成员的基因。 hTcf-4仅在与β-连环蛋白相关时才转录转录。 发现APC < - / - >结肠癌细胞的核含有一个稳定的β-连环蛋白-hTCF-4复合物,其通过Tcf报告基因的转录测量而具有组成型活性。 重新引入APC从hTcf4中除去β-连环蛋白,并废除转录反式激活。 由APC功能丧失引起的TCF靶基因的组成转录可能是结肠上皮早期转化的关键事件。 这里还显示,在结肠直肠肿瘤中发现的突变APC基因的产物在调节β-连环蛋白/ Tcf-4转录激活中是缺陷的。 此外,具有完整APC基因的结肠直肠肿瘤显示含有改变功能显着磷酸化位点的β-连环蛋白的微妙活化突变。 这些结果表明,β-连环蛋白的调节对于APC的肿瘤抑制作用至关重要,并且该调节可以通过APC或β-连环蛋白的突变来规避。
    • 9. 发明申请
    • SAFE SEQUENCING SYSTEM
    • 安全排序系统
    • WO2012142213A2
    • 2012-10-18
    • PCT/US2012/033207
    • 2012-04-12
    • THE JOHNS HOPKINS UNIVERSITYVOGELSTEIN, BertKINZLER, Kenneth W.PAPADOPOULOS, NickolasKINDE, Isaac
    • VOGELSTEIN, BertKINZLER, Kenneth W.PAPADOPOULOS, NickolasKINDE, Isaac
    • C12Q1/68C12N15/11
    • C12Q1/6874C12Q1/6806C12Q1/6869C12Q1/6876C12Q2563/179C12Q2600/158C12Q2535/122C12Q2565/514
    • The identification of mutations that are present in a small fraction of DNA templates is essential for progress in several areas of biomedical research. Though massively parallel sequencing instruments are in principle well-suited to this task, the error rates in such instruments are generally too high to allow confident identification of rare variants. We here describe an approach that can substantially increase the sensitivity of massively parallel sequencing instruments for this purpose. One example of this approach, called "Safe-SeqS" for (Safe-Sequencing System) includes (i) assignment of a unique identifier (UID) to each template molecule; (ii) amplification of each uniquely tagged template molecule to create UID-families; and (iii) redundant sequencing of the amplification products. PCR fragments with the same UID are truly mutant ("super-mutants") if ≥95% of them contain the identical mutation. We illustrate the utility of this approach for determining the fidelity of a polymerase, the accuracy of oligonucleotides synthesized in vitro , and the prevalence of mutations in the nuclear and mitochondrial genomes of normal cells.
    • 存在于DNA模板的一小部分中的突变的鉴定对于在几个生物医学研究领域的进展是必不可少的。 尽管大规模并行测序仪器原则上非常适合于此任务,但是这些仪器中的错误率通常太高,无法确定罕见的变体。 我们在这里描述了一种可以显着增加大规模并行测序仪器对此目的的灵敏度的方法。 这种方法的一个例子是(Safe-Sequencing System),称为“Safe-SeqS”,包括(i)将唯一标识符(UID)分配给每个模板分子; (ii)每个唯一标记的模板分子的扩增以产生UID家族; 和(iii)扩增产物的冗余测序。 具有相同UID的PCR片段是真正的突变体(“超突变体”),如果其中95%含有相同的突变。 我们说明了这种方法用于确定聚合酶的保真度,体外合成的寡核苷酸的准确性以及正常细胞的核和线粒体基因组中突变的流行率的效用。